Lista de obras - Antoine Thiery-vuillemin

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

artículo científico publicado en 2017

A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.

artículo científico publicado en 2008

Anticancer therapy in patients with porphyrias: evidence today

scientific article published on 01 March 2008

Cancer du rein : tendances et perspectives

scientific article published on 01 December 2018

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

artículo científico publicado en 2015

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

artículo científico publicado en 2014

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

artículo científico publicado en 2011

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

artículo científico publicado en 2023

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour

artículo científico publicado en 2011

Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.

artículo científico publicado en 2010

Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies

scientific article published on 07 November 2018

Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.

artículo científico publicado en 2012

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.

artículo científico publicado en 2014

Efficacy of trabectedin in metastatic solitary fibrous tumor.

artículo científico publicado en 2011

Efficacy, safety and cost of eribulin in patients with metastatic breast cancer

artículo científico publicado en 2015

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

artículo científico publicado en 2012

Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice

artículo científico publicado en 2017

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol

artículo científico publicado en 2019

Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer

scientific article published on 15 October 2012

Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma.

artículo científico publicado en 2017

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma

artículo científico publicado en 2014

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer

artículo científico publicado en 2016

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer

artículo científico publicado en 2012

Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study

article

Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy

artículo científico publicado en 2015

Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis

artículo científico publicado en 2011

In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

artículo científico publicado en 2015

Metabolic impact of androgen deprivation therapy for prostate cancer

artículo científico publicado en 2012

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial

artículo científico publicado en 2016

Molecularly targeted agents: their promise as cancer chemopreventive interventions.

artículo científico publicado en 2005

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study proto

artículo científico publicado en 2018

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

artículo científico publicado en 2016

Prevalence and management of pain in patients with metastatic cancer in Franche-Comté

artículo científico publicado en 2016

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

artículo científico publicado en 2016

Response rates: a valuable signal of promising activity?

artículo científico publicado en 2009

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.

artículo científico

Safety profile of new anticancer drugs.

artículo científico publicado en 2010

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

artículo científico publicado en 2018

Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact

scientific article published on 07 August 2010

Specific anticancer treatments in the last 3 months of life: a French experience.

artículo científico publicado en 2012

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

scientific article published on 03 June 2018

Targeted therapy and breast cancer: state of the art

artículo científico publicado en 2012

[Cytoreduction nephrectomy: No future?]

artículo científico publicado en 2018

[DNA damage repair: An emerging strategy in metastatic prostate cancer]

artículo científico publicado en 2018

[Follow-up in patients with early breast cancer]

artículo científico publicado en 2011

[Immunotherapy: an emerging strategies against prostate castration resistant cancer]

scientific article published on 01 July 2012

[Induction chemotherapy in patients with head and neck cancer]

artículo científico publicado en 2006

[Oligometastatic prostate cancer management]

artículo científico publicado en 2019

[Relapse surveillance of patients with testicular germ cell tumor]

scientific article published on 05 September 2019

[Sexual dysfunctions of patients treated with orchidectmoy, chemotherapy and retroperitoneal lymphadenectomy, need for systematic andrological care?]

artículo científico publicado en 2019

[Side effects of chemotherapy for testicular cancers and post-cancer follow-up]

artículo científico publicado en 2019

[Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer]

scientific article published on 03 January 2019

[Treatment of bladder outlet obstruction in locally advanced prostate cancer]

artículo científico publicado en 2013

Lista de obras de Antoine Thiery-vuillemin

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.

Anticancer therapy in patients with porphyrias: evidence today

Cancer du rein : tendances et perspectives

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.

Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour

Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.

Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies

Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.

Efficacy and Safety of Sequential Use of Everolimus in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Bevacizumab With or Without Interferon Therapy: Results From the European AVATOR Study.

Efficacy of trabectedin in metastatic solitary fibrous tumor.

Efficacy, safety and cost of eribulin in patients with metastatic breast cancer

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol

Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer

Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma.

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer

Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study

Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy

Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis

In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

Metabolic impact of androgen deprivation therapy for prostate cancer

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial

Molecularly targeted agents: their promise as cancer chemopreventive interventions.

Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study proto

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

Prevalence and management of pain in patients with metastatic cancer in Franche-Comté

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

Response rates: a valuable signal of promising activity?

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.

Safety profile of new anticancer drugs.

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact

Specific anticancer treatments in the last 3 months of life: a French experience.

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Targeted therapy and breast cancer: state of the art

[Cytoreduction nephrectomy: No future?]

[DNA damage repair: An emerging strategy in metastatic prostate cancer]

[Follow-up in patients with early breast cancer]

[Immunotherapy: an emerging strategies against prostate castration resistant cancer]

[Induction chemotherapy in patients with head and neck cancer]

[Oligometastatic prostate cancer management]

[Relapse surveillance of patients with testicular germ cell tumor]

[Sexual dysfunctions of patients treated with orchidectmoy, chemotherapy and retroperitoneal lymphadenectomy, need for systematic andrological care?]

[Side effects of chemotherapy for testicular cancers and post-cancer follow-up]

[Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer]

[Treatment of bladder outlet obstruction in locally advanced prostate cancer]